Quality Control of Cortex Magnoliae Officinalis

Y. Jiang,C. Fiorini,B. Fabre,B. David,Y. Barbin
DOI: https://doi.org/10.1055/s-0029-1234711
IF: 3.007
2009-01-01
Planta Medica
Abstract:Cortex Magnoliae officinalis is the dried stem bark, root bark or branch bark of Magnolia officinalis Rehd. et Wils. or Magnolia officinalis var. biloba Rehd. et Wils. (Magnoliaceae). It has been used as traditional Chinese medicine for more than 2000 years for the treatment of epigastric stuffiness, vomiting and diarrhea, abdominal distention and constipation, cough and dyspnea, etc. It will be introduced as a monograph in the future European Pharmacopoeia, so the quality standard of this crude drug has been drafted, including identification, test (loss of drying, total ash, ash insoluble in hydrochloric acid, and aristolochic acid), as well as assay of magnolol and honokiol by HPLC. The TLC identification used toluene:ethyl acetate:methanol (30:2:1 v/v/v) as mobile phase, cineole and honokiol as references, and 1% vanillin sulphuric acid as spray reagent. The different test items were examined according to the corresponding protocols in present European Pharmacopoeia, and their limits were made on the basis of the results of 22 batch samples. However, no aristolochic acid was detected in this plant. The HPLC quantitation of magnolol and honokiol was performed on a reversed-phase C18 column with acetronitrile:0.5% acetic acid (60:40) as mobile phase at a flow-rate of 1.2ml/min, and the detected wavelength was set at 290nm. This method was validated for its selectivity, linearity, precision and accuracy. The samples from different sources were analyzed, and the contents of magnolol and honokiol were found to be 0.07–96.51mg/g and 0.05–91.91mg/g, respectively. The large quantitative differences observed do justify careful controls to ensure the quality consistency of this crude material.
What problem does this paper attempt to address?